Getinge

Getinge Market capitalization

The The market capitalization of Getinge (GETI B.ST) as of Nov 20, 2026 is 53.83 B SEK. In the previous year, The market capitalization was 53.83 B SEK — a change of 0.00% (lower).

Market capitalization

53.83 BSEK

YoY

0.00%

Last updated:

In 2025, Getinge's market cap stood at 53.83 B SEK, a 0.00% increase from the 53.83 B SEK market cap in the previous year.

The Getinge Market capitalization history

  • 3 Years

  • 10 Years

  • 25 Years

  • Max

Market capitalization
Date
Market capitalization
Jan 1, 2018
53.83 B SEK
Jan 1, 2019
53.83 B SEK
Jan 1, 2020
53.83 B SEK
Jan 1, 2021
53.83 B SEK
Jan 1, 2022
53.83 B SEK
Jan 1, 2023
53.83 B SEK
Jan 1, 2024
53.83 B SEK
Jan 1, 2025
53.83 B SEK
The Getinge Market capitalization history
YEARMarket capitalizationYoY
53.83 BSEK0.00%
53.83 BSEK0.00%
53.83 BSEK0.00%
53.83 BSEK0.00%
53.83 BSEK0.00%
53.83 BSEK0.00%
53.83 BSEK0.00%
53.83 BSEK0.00%
53.83 BSEK0.00%
53.83 BSEK0.00%
53.83 BSEK0.00%
53.83 BSEK—

Access this data via the Eulerpool API

100,000 free requests/mo · no credit card

Getinge Stock analysis

What does Getinge do? Getinge AB is a globally leading company that offers innovative solutions and products for the healthcare industry. The company was founded in Sweden in 1904 and has since had a long history in the medical technology industry. Getinge AB is known for its leading position in the field of medical equipment, including autoclaves, sterilizers, washer-disinfectors, and ventilators. The business model of Getinge AB is focused on the needs of customers in the healthcare sector. The company operates five business areas: Acute Care Therapies, Infection Control, Extended Care, Life Science, and Surgical Workflows. Each of these business areas focuses on specific needs and requirements within the healthcare sector. Getinge AB aims to offer its customers innovative and high-quality products and services worldwide. The company promotes continuous innovation and aims to leverage the potential of cutting-edge technologies in the market to develop solutions that improve the lives of patients and healthcare professionals. Various divisions and products - Acute Care Therapies: One of Getinge AB's main products in the Acute Care Therapies area is extracorporeal membrane oxygenation machines (ECMO). These systems are used to support patients with respiratory failure. Another important product line is the Intra-Aortic Balloon Pump (IABP), which is used to support patients with heart failure or cardiogenic shock. - Infection Control: In the Infection Control area, Getinge AB focuses on developing products to control infections that can be caused by hospital environments and medical instruments. This includes sterilization and disinfection devices, as well as cleaning and disinfection agents. - Extended Care: The Extended Care business area offers products and solutions for non-acute patient care. The company focuses on offering innovative products and services that contribute to improving the quality of care and reducing costs. This includes products such as patient beds, mattresses, and assistive devices. - Life Science: In the Life Science area, Getinge AB offers products and services for the biopharmaceutical industry and for research and development. The company specializes in the development of cleanroom technology, which helps make the production of medications safer and more efficient. - Surgical Workflows: The Surgical Workflows business area focuses on optimizing surgical workflows and increasing efficiency. Getinge AB offers products and services such as operating tables, anesthesia and monitoring systems, and wound care products. In summary, Getinge AB has a long history in the medical technology industry and is a leading company in the field. The company operates five business areas that focus on specific needs and requirements within the healthcare sector. Getinge AB aims to offer its customers worldwide innovative and high-quality products and services. The product range includes a wide range of innovative medical technology products, including autoclaves, sterilizers, washer-disinfectors, ventilators, cleaning and disinfection agents, and other medical technology products. Getinge is one of the most popular companies on Eulerpool.

Market capitalization Details

Exploring Getinge's Market Capitalization

Getinge's market capitalization represents the total dollar market value of the company’s outstanding shares of stock. It is calculated by multiplying the company's shares outstanding by the current market price of one share. This metric is a vital indicator of a company’s size, strength, and overall market value.

Year-to-Year Comparison

A yearly comparison of Getinge's market capitalization provides investors and analysts insights into its growth and valuation trends. An increase signifies market confidence and business expansion, while a decrease may point towards declining market value or business contractions.

Impact on Investments

Getinge's market capitalization plays a pivotal role in investment decisions. It aids investors in assessing the company's risk and return profiles. Larger companies are often considered more stable but may offer lower growth potential, while smaller companies might offer significant growth prospects but come with higher risk.

Interpreting Market Capitalization Fluctuations

Variations in Getinge’s market capitalization can be attributed to several factors, including changes in stock price, outstanding shares, and market sentiment. Understanding these fluctuations helps investors evaluate the company's current standing and future potential in the competitive landscape.

Frequently Asked Questions about Getinge stock

The market capitalization of Getinge is 53.83 B SEK in 2025.

The market capitalization of Getinge changed from 53.83 B SEK to 53.83 B SEK, representing a 0.00% change. The value is lower than the previous year.

On Eulerpool you can find the complete historical development of The market capitalization Getinge since 2006 – with annual values, charts, and detailed analysis.

Market capitalization (German: Market capitalization, English: market capitalisation or market cap) is the calculated total value of all shares of a publicly traded company. The market capitalization of a company reflects the current market consensus on the value of the equity of a publicly traded company. It is determined by the supply and demand for the company's shares. Thus, market capitalization is significantly influenced by expectations in the stock market regarding the future earnings power of the company and, therefore, can be subject to significant fluctuations.

Number of shares * share price = market capitalization

To evaluate The market capitalization's SEK, it is essential to compare it with peers in the same industry and sector. On Eulerpool, you can find direct industry comparisons for The market capitalization.

A 'good' SEK varies by industry and company stage. On Eulerpool, you can compare The market capitalization's Getinge with sector peers and the industry average to assess whether it is attractive.

Access this data via the Eulerpool API

100,000 free requests/mo · no credit card

Valuation — Getinge

All Key Metrics — Getinge